<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Dopamine-glutamate interaction and antipsychotics mechanism of action : Implication for new pharmacological strategies in psychosis</dc:title>
  <dc:creator>DE BARTOLOMEIS, A</dc:creator>
  <dc:creator>FIORE, G</dc:creator>
  <dc:creator>IASEVOLI, F</dc:creator>
  <dc:relation>Current pharmaceutical design -- Curr. pharm. des, ISSN 1381-6128, Vol. 11 (27) , pp. 3561-3594</dc:relation>
  <dc:date>2005</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Article</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Bentham Science</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>34 p. ; 346 ref</dc:format>
  <dc:subject xml:lang="fr">Aminoacide excitateur</dc:subject>
  <dc:subject xml:lang="fr">Catécholamine</dc:subject>
  <dc:subject xml:lang="fr">Neurotransmetteur</dc:subject>
  <dc:subject xml:lang="fr">Antipsychotique</dc:subject>
  <dc:subject xml:lang="fr">Article synthèse</dc:subject>
  <dc:subject xml:lang="fr">Cyclosérine</dc:subject>
  <dc:subject xml:lang="fr">Densité postsynaptique</dc:subject>
  <dc:subject xml:lang="fr">Dopamine</dc:subject>
  <dc:subject xml:lang="fr">Glutamate</dc:subject>
  <dc:subject xml:lang="fr">Glycine</dc:subject>
  <dc:subject xml:lang="fr">Interaction</dc:subject>
  <dc:subject xml:lang="fr">Mécanisme action</dc:subject>
  <dc:subject xml:lang="fr">NMDA</dc:subject>
  <dc:subject xml:lang="fr">Neuroleptique</dc:subject>
  <dc:subject xml:lang="fr">Psychose</dc:subject>
  <dc:subject xml:lang="fr">Recherche développement</dc:subject>
  <dc:subject xml:lang="fr">Schizophrénie</dc:subject>
  <dc:subject xml:lang="en">Excitatory aminoacid</dc:subject>
  <dc:subject xml:lang="en">Catecholamine</dc:subject>
  <dc:subject xml:lang="en">Neurotransmitter</dc:subject>
  <dc:subject xml:lang="en">Antipsychotic</dc:subject>
  <dc:subject xml:lang="en">Review</dc:subject>
  <dc:subject xml:lang="en">Cycloserine</dc:subject>
  <dc:subject xml:lang="en">Postsynaptic density</dc:subject>
  <dc:subject xml:lang="en">Dopamine</dc:subject>
  <dc:subject xml:lang="en">Glutamate</dc:subject>
  <dc:subject xml:lang="en">Glycine</dc:subject>
  <dc:subject xml:lang="en">Interaction</dc:subject>
  <dc:subject xml:lang="en">Mechanism of action</dc:subject>
  <dc:subject xml:lang="en">NMDA</dc:subject>
  <dc:subject xml:lang="en">Neuroleptic</dc:subject>
  <dc:subject xml:lang="en">Psychosis</dc:subject>
  <dc:subject xml:lang="en">Research and development</dc:subject>
  <dc:subject xml:lang="en">Schizophrenia</dc:subject>
  <dc:subject xml:lang="en">AMPAkine</dc:subject>
  <dc:subject xml:lang="en">D-cycloserine</dc:subject>
  <dc:subject xml:lang="en">Glycine</dc:subject>
  <dc:subject xml:lang="en">Homer</dc:subject>
  <dc:subject xml:lang="en">NMDA</dc:subject>
  <dc:subject xml:lang="en">Postsynaptic density</dc:subject>
  <dc:subject xml:lang="en">mGluR type II</dc:subject>
  <dc:subject xml:lang="en">schizophrenia</dc:subject>
  <dc:subject xml:lang="es">Aminoácido excitador</dc:subject>
  <dc:subject xml:lang="es">Catecolamina</dc:subject>
  <dc:subject xml:lang="es">Neurotransmisor</dc:subject>
  <dc:subject xml:lang="es">Antipsicótico</dc:subject>
  <dc:subject xml:lang="es">Artículo síntesis</dc:subject>
  <dc:subject xml:lang="es">Cicloserina</dc:subject>
  <dc:subject xml:lang="es">Dopamina</dc:subject>
  <dc:subject xml:lang="es">Glutamato</dc:subject>
  <dc:subject xml:lang="es">Glicina</dc:subject>
  <dc:subject xml:lang="es">Interacción</dc:subject>
  <dc:subject xml:lang="es">Mecanismo acción</dc:subject>
  <dc:subject xml:lang="es">NMDA</dc:subject>
  <dc:subject xml:lang="es">Neuroléptico</dc:subject>
  <dc:subject xml:lang="es">Psicosis</dc:subject>
  <dc:subject xml:lang="es">Investigación desarrollo</dc:subject>
  <dc:subject xml:lang="es">Esquizofrenia</dc:subject>
  <dc:subject>002B02B03: Psycholeptiques: tranquillisant, neuroleptique. / Psycholeptics: tranquillizer, neuroleptic.</dc:subject>
  <dc:subject>770-: Psychologie. Psychanalyse. Psychiatrie / Psychology. Psychoanalysis. Psychiatry</dc:subject>
  <dc:subject>770-E: Psychopharmacologie / Psychopharmacology</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 17073268</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>